BP 3rd-quarter outlook: ‘dreadful’

Stephen Beard Sep 25, 2007
HTML EMBED:
COPY

BP 3rd-quarter outlook: ‘dreadful’

Stephen Beard Sep 25, 2007
HTML EMBED:
COPY

TEXT OF STORY

Doug Krizner: In Europe, stocks are lower, particularly energy shares. British Petroleum is down after the company’s CEO was quoted by the Financial Times saying third quarter revenue will be dreadful. How can that be with crude oil trading at $80 a barrel? Here’s Stephen Beard.


Stephen Beard: BP’s third-quarter revenues are “dreadful.” That, says The Financial Times, is the exact word the new chief executive used to describe the company’s performance.

Tony Hayward is reported to have told staff to expect a big shake-up. He apparently believes there are too many layers of management and poor communications. BP’s bottom line is still suffering, largely because of its problems in the United States.

Analyst Peter Kemp says BP’s refinery — or downstream — revenues are still being hit by the Texas City Refinery fire in 2005.

Peter Kemp: Across the whole portfolio in the U.S. — the downstream portfolio — they are having to introduce new methods and procedures and clean up their act.

BP has also lost money on the delay in production from new projects in the Gulf of Mexico. But the company expects revenues to improve towards the end of the year.

In London, this is Stephen Beard for Marketplace.

We’re here to help you navigate this changed world and economy.

Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.

In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.

Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.